In early stage HCC, the CSPH group had a higher prevalence of hepatitis C and worse liver function markers (Child–Pugh grade, ALBI score, MELD score, prothrombin time, albumin concentration, and bilirubin concentration) as well as lower platelet count. The gene discussed is F2; the disease is hepatitis C virus infection.